NHS semaglutide spending in London has surged from £242K in 2019 to £15.6m in 2024. Find out what's driving demand and the ...

Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. 5, after market close. Since the ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

A report published last week in “The Lancet Diabetes & Endocrinology” strives to redefine obesity. An international group convened to examine the longstanding concept and are recommending better ...

For years, medical experts have defined obesity primarily based on body mass index, which measures stored fat by calculating height and weight, to determine a person’s health risks. Major public ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Medical experts have urged a shift away from the Body Mass Index (BMI) as the main yardstick to determine obesity as it does not factor in body fat levels. The prevalent method is so flawed that it ...

The solution?: Lose weight. But the report, published in the journal The Lancet Diabetes & Endocrinology on Tuesday, suggested that having obesity according to the BMI scale doesn't mean a person ...

Chart: The Economist By coincidence (they started ... have developed a better way of diagnosing obesity—one that distinguishes when it has become pathological. To diagnose their newly defined ...